Altamira Therapeutics .(CYTO) - 2020 Q2 - Earnings Call Presentation

Corporate Presentation September 2020 NASDAQ: EARS | Contact: investors@aurismedical.com Innovative Treatments in Neurotology and CNS Disorders Forward-looking Statements This presentation may contain statements that constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are statements other than historical facts and may include statements that address future operating, financi ...